TABLE 4.
Test2: change from pre to post within and between groups |
||||||
Within group |
Between groups |
|||||
EUM (n = 16) |
FHA (n = 14) |
|||||
p-Value | p-Value | p-Value | ||||
Prolactin (μg/L) | 176.9 ± 34.1 | <0.001 | 148.4 ± 34.1 | <0.001 | 28.5 ± 48.2 | 0.554 |
ACTH (μg/L) | 67.2 ± 12.1 | <0.001 | 65.1 ± 12.5 | <0.001 | −2.1 ± 17.4 | 0.902 |
Cortisol (nmol/L) | 53.8 ± 37.5 | 0.151 | 98.6 ± 37.5 | 0.008 | −44.9 ± 53.0 | 0.397 |
GH (μg/L) | 15.7 ± 2.2 | <0.001 | 12.9 ± 2.1 | <0.001 | 2.8 ± 3.0 | 0.355 |
IGF-1 (μg/L) | 28.0 ± 4.6 | <0.001 | 39.3 ± 4.3 | <0.001 | −11.3 ± 6.3 | 0.074 |
IGFBP-3 (μg/L) | 0.6 ± 0.6 | 0.321 | 2.1 ± 0.5 | <0.001 | −1.5 ± 0.8 | 0.048 |
Insulin (pmol/L) | 6.2 ± 14.8 | 0.675 | 13.7 ± 14.2 | 0.332 | −7.5 ± 20.5 | 0.712 |
Prolactin:cortisol | 0.60 ± 0.15 | <0.001 | 0.23 ± 0.15 | 0.116 | 0.37 ± 0.21 | 0.071 |
Cortisol:insulin | 0.004 ± 0.003 | 0.202 | 0.008 ± 0.003 | 0.005 | −0.004 ± 0.004 | 0.310 |
GH:cortisol | 0.058 ± 0.010 | <0.001 | 0.329 ± 0.010 | 0.001 | 0.025 ± 0.014 | 0.082 |
GH:insulin | 5.318 ± 1.450 | <0.001 | 4.376 ± 1.391 | 0.002 | 0.942 ± 2.008 | 0.639 |
IGF-1:IGFBP-3 | 0.92 ± 1.22 | 0.454 | −2.04 ± 1.2 | 0.080 | 2.96 ± 1.70 | 0.081 |
IGF:cortisol | 0.001 ± 0.098 | 0.991 | −0.051 ± 0.093 | 0.585 | 0.052 ± 0.135 | 0.700 |
BDNF (μg/L) | 34.4 ± 23.5 | 0.143 | 96.5 ± 22.9 | <0.001 | −62.1 ± 32.8 | 0.058 |
Data shown as mean and standard error. EUM, Eumenorrheic athletes; athletes with FHA, functional hypothalamic amenorrhea; ACTH, adrenocorticotropic hormone; BDNF, brain derived neurotrophic factor; GH, growth hormone; IGF-1, insulin like growth factor 1; IGFBP-3, insulin like growth factor binding protein 3.